Resultados de la búsqueda 121-130 of 10318 for Raised liver enzymes

1. Hematología - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

2. Insuficiencia hepática aguda - Síntomas y causas - Mayo Clinic

   https://www.clinicalkey.com. Accessed July 2, 2024. Acute liver failure. Merck Manual Professional Version. https://www.merckmanuals.com/professional/hepatic- ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

4. Hematología - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

5. Mayo Clinic Digestive Diseases Physician Update - July 2026

   Page 1.

6. Hematología - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

7. Cirugía - Ensayos clínicos - Mayo Clinic

   Levels of bladder cancer-derived extracellular ... When the ascending aorta tears or ruptures, the risk dying is high even if surgery is done as soon as possible.

8. Enfermedad del hígado graso (esteatosis hepática asociada a disfunción metabólica) - Etapas - Mayo Clinic

   Increased MASH-associated liver cancer in younger demographics. Hepatology Communications. 2025; doi:10.1097/HC9.0000000000000629. Guimarães JSF, et al ...

9. Hematología - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

10. Mayo Clinic Digestive Diseases Physician Update - October 2026

    Page 1.